"Horisont 2020 programm" projekt MMVCM15035R
MMVCM15035R (633724) "Sõeluuringud väga enneaegsete laste tervise parandamiseks Euroopas (1.09.2015−31.01.2019)", Heili Varendi, Tartu Ülikool, Arstiteaduskond, Lastekliinik, Tartu Ülikool, Meditsiiniteaduste valdkond, kliinilise meditsiini instituut.
633724
MMVCM15035R
Sõeluuringud väga enneaegsete laste tervise parandamiseks Euroopas
Screening to improve Health In very Preterm infantS in Europe
SHIPS
1.09.2015
31.01.2019
Teadus- ja arendusprojekt
Horisont 2020 programm
ETIS klassifikaatorAlamvaldkondCERCS klassifikaatorFrascati Manual’i klassifikaatorProtsent
3. Terviseuuringud3.7. Kliiniline meditsiinB660 Pediaatria 3.2. Kliiniline meditsiin (anestesioloogia, pediaatria, sünnitusabi ja günekoloogia, sisehaigused, kirurgia, stomatoloogia, neuroloogia, psühhiaatria, radioloogia, terapeutika, otorinolarüngoloogia, oftalmoloogia)100,0
AsutusRiikTüüp
Euroopa Komisjon
PerioodSumma
01.09.2015−31.01.2019100 062,00 EUR
100 062,00 EUR

Sõeluuringud väga enneaegsete laste tervise parandamiseks Euroopas
Very preterm birth is a principal determinant of motor and cognitive impairment in later life. About 50 000 infants in the EU survive very preterm birth annually and are at much higher risk of cerebral palsy, visual and auditory deficits, impaired cognitive ability, psychiatric disorders and behavioural problems than infants born at term. However, the long term prognosis at initial discharge from hospital for each individual infant is unknown. Follow-up screening and prevention programmes aim to identify health problems early, enable interventions to improve outcome and to allow optimal management of health care. Despite the recognised importance of these programmes, little is known about their actual application and impact. These programmes consume significant resources because of the multidisciplinary staff required for clinical and developmental assessments and interventions, the coordination required to maintain contact with children after discharge and the time input from families. This project uses a unique resource – the EPICE cohort of 6675 babies born before 32 weeks of gestational age and surviving to discharge home in 18 geographically diverse regions in 2011/2012 – to assess the impact of these screening programmes on health, care and quality of life for very preterm infants and their families as well as on coverage, ability to meet needs, health equity and costs at the population-level. It will also generate new knowledge about assessment tools and methods. Four inter-related studies will be carried out in 11 EU countries by a multi-disciplinary consortium of clinicians (in obstetrics, paediatrics, and child development), researchers (in epidemiology, health services research and health economics) and a user organisation. Partners have the expertise to implement this project and the national and international renown to translate its result into better programmes and policies.
KirjeldusProtsent
Rakendusuuring100,0
http://www.epiceproject.eu/en/
AsutusRollRiikTüüpKommentaar
European Foundation for the Care of Newborn InfantspartnerSaksamaa Liitvabariikfond
Hvidovre HospitalpartnerTaani KuningriikTA asutus
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)koordinaatorPrantsuse VabariikTA asutus
KAROLINSKA INSTITUTETpartnerRootsi KuningriikTA asutus
OSPEDALE PEDIATRICO BAMBINO GESUpartnerItaalia VabariikTA asutus
PHILIPPS UNIVERSITAET MARBURGpartnerSaksamaa Liitvabariikülikool
Radboud University Nijmegen Radboud Universiteit NijmegenpartnerMadalmaade Kuningriikülikool
THE UNIVERSITY OF WARWICKpartnerSuurbritannia ja Põhja-Iiri Ühendkuningriikülikool
UNIVERSIDADE DO PORTOpartnerPortugali Vabariikülikool
UNIVERSITEIT ANTWERPENpartnerBelgia Kuningriikülikool
UNIVERSITY OF LEICESTERpartnerSuurbritannia ja Põhja-Iiri Ühendkuningriikülikool
UNIWERSYTET MEDYCZNY IM KAROLA MARCINKOWSKIEGO W POZNANIUpartnerPoola Vabariikülikool